FDA Investigator Joy F Canlas
Joy F Canlas has conducted inspections on 29 sites in 1 countries as of 29 Jul 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
29
Last Inspection Date:
29 Jul 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Joy F Canlas:
Alois P Provost,
Andrew F Cohen,
Andrew J Molesky,
Anthony M Criscuolo, Jr,
Ayorinde O Babalola,
Barbara J Maulfair,
Benjamin Bustamante,
Brian M Brodman,
Cary Greene,
Christian Parra,
Craig W Swanson,
Diane B Radice,
Emilio Z Azukwu,
Eric Rothschild,
Feryal Ahmad,
Frank J Marciniak,
Gianine E Tompkins,
Gobiga Vanniyasingam,
Jane C Chen,
Jason Kwong,
Joseph Duca,
Julianna M Chedid,
Karen F Tomaziefski,
Katrina M D'egidio,
Kristy L Bonner,
Laishan L Lam,
Lawrence R Johnson,
Leticia S Jones,
Li Li,
Melissa B Libby,
Noreen Kurzam,
Onieka T Carpenter,
Peter M Trunk,
Phillip O Mathis,
Remache,
Sandra Kershaw,
Schultz,
Seemay A Lee,
Sharon Ferraro,
Sherri J Liu,
Shreya Shah,
Sinai I Davis,
Sonia E Ortiz,
Susan M Halsted,
Tara K Carmody,
Tonia F Bernard,
Vaishali J Patel,
Valerie C Reed,
Willy A Orantes
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more